<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02859675</url>
  </required_header>
  <id_info>
    <org_study_id>BRONDEL Ass INRA 2011</org_study_id>
    <nct_id>NCT02859675</nct_id>
  </id_info>
  <brief_title>Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease</brief_title>
  <acronym>Smell&amp;Crohn</acronym>
  <official_title>Olfactogustatory Perception, Eating Behaviour and Inflammation in Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will improve our understanding of the mechanisms underlying anorexia in persons
      with Crohn's disease flare-ups. The practical spin-off from this research is potentially very
      important for the management of nutritional disorders associated with the disease by guiding
      diets towards foods that correspond to patients' preferences and/or to modified tastes. In
      addition, the results could lead to the identification of sensory markers that herald an
      inflammatory flare-up of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 7, 2013</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Modification of sweet taste</measure>
    <time_frame>through the study completion up to 10 years</time_frame>
    <description>the measurement of detection thresholds consists in presenting to the participants in order of increasing concentrations, series of forced-choice triangular tests</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Olfactogustatory Perception</condition>
  <arm_group>
    <arm_group_label>Crohn and anti-TNF treatment</arm_group_label>
    <description>Tests at 3 or 4 weeks after the beginning of anti-TNF treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Crohn and without anti-TNF treatment</arm_group_label>
    <description>tests performed according to patient availability</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>tests performed according to patient availability</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>triangular test</intervention_name>
    <description>metabolic state, impedance measurement, potential flavours evoked by sucrose,</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Crohn and anti-TNF treatment</arm_group_label>
    <arm_group_label>Crohn and without anti-TNF treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>sampling of 2 mL</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Crohn and anti-TNF treatment</arm_group_label>
    <arm_group_label>Crohn and without anti-TNF treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <description>Stunkard, PrefQuest</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Crohn and anti-TNF treatment</arm_group_label>
    <arm_group_label>Crohn and without anti-TNF treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        understanding of the mechanisms underlying anorexia in persons with Crohn's disease
        flare-ups
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        For patients :

        Inclusion Criteria:

          -  Age between 18 and 60 years,

          -  Diagnosis of Crohn's disease according to clinical, endoscopic, histological,
             radiological and biochemical criteria as defined by the European Consensus Conference,

          -  Men or women who have provided consent and willing to cooperate.

        Exclusion Criteria:

          -  Chronic inflammatory intestinal disease (CIID) other than Crohn's disease:
             haemorrhagic rectocolitis, undetermined colitis, microscopic colitis.

          -  Intercurrent disease (diabetes and metabolic disease, liver cirrhosis, progressive
             cancer, acute or chronic infection, Human Immunodeficiency Virus HIV),

          -  Organ failure (respiratory, heart, or renal failure, neurological disorders),

          -  Intolerance to gluten,

          -  Treatments (other than those used for Crohn's disease) able to interfere with food
             intake,

          -  Aversion to foods consumed or smelled,

          -  Poor understanding of cognitive tasks required.

          -  Crohn's disease complicated by an abscess or infectious complication

          -  Acute Crohn's disease defined by a CDAI score &gt; 150

        For Controls:

        Inclusion Criteria:

          -  Adult person

          -  Without follow-up for a chronic pathology

          -  Having given its consent

        Exclusion Criteria:

          -  Protected adult

          -  Person not affiliated to a social security system

          -  Pregnant or breastfeeding woman

          -  Active smoker

          -  No one who does not speak French

          -  Taking treatment that interferes with taste or acts on the central nervous system
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurent BRONDEL</last_name>
    <phone>06.77.10.86.53</phone>
    <phone_ext>33</phone_ext>
    <email>laurent.brondel@u-bourgogne.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent BRONDEL</last_name>
      <phone>06 77 10 86 53</phone>
      <phone_ext>33</phone_ext>
      <email>laurent.brondel@u-bourgogne.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2016</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

